Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Art & Psychiatry
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Conference Oration
Conference Summary
Continuing Medical Education
Cosmetic Dermatology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
Editor Speaks
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Miscellaneous Letter
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News & Views
Observation Letter
Observation Letters
Original Article
Original Contributions
Pattern of Skin Diseases
Pediatric Dermatology
Pediatric Rounds
Presedential Address
Presidential Address
Presidents Remarks
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Study Letter
Study Letters
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapy Letter
Therapy Letters
View Point
What’s new in Dermatology
View/Download PDF

Translate this page into:

89 (
); 1-4

Letter from an Editor: Bidding Adieu

Editor-in-Chief, IJDVL, India
Corresponding author: Dr. Saumya Panda, Consultant Dermatologist, Belle Vue Clinic, Kolkata, 700028, West Bengal, India,
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Panda S. Letter from an Editor: Bidding Adieu. Indian J Dermatol Venereol Leprol 2023;89:1-4.

Medical journal editors walk a fine line. They must aspire to impartiality, open-mindedness, and intellectual honesty. They must try to select material for its merit, interest to readers, and originality alone. They also want their journals to have a voice and a personality. If they are doing their jobs well, they should give no favors, and they should have no friends.

– Jerome Kassirer, Unanticipated Outcomes: A Medical Memoir, 2017

As the editor of the Indian Journal of Dermatology, Venereology & Leprology (IJDVL), this is my final message to you all from the bully pulpit. Since 2017, it has been an interesting six years, with its share of more ups than downs, but hardly a dull moment. It has indeed been a unique honour to serve as an editor of a journal of such standing for two consecutive stints, and I am thankful to the Indian Association of Dermatologists, Venereologists & Leprologists (IADVL) for according me this privilege. As I leave, it gives me great satisfaction to report that the journal is going from strength to strength.

Despite an intervening two years of a brutally disruptive pandemic that was definitely challenging for reviewers and editors alike,1 also considering that this was exactly the period during which the journal made the transition, not only from one publisher to another, but also from one manuscript management system to an entirely new one, it was no mean feat that our record of punctuality in publishing remained intact. This gains more significance when we take into account the fact that the transfer process itself was anything but smooth as our erstwhile publisher came up short on upholding publishing industry standards in several areas, putting our data in jeopardy.2

We continue to adhere to a publication model known as ‘platinum open access’, meaning that neither the authors nor the readers have to pay anything in order to publish or have complete access to the data published in the journal.3 Our author base is expanding all the while, having reached literally all corners of the world, helping IJDVL to establish itself as a truly global journal. The number of expert peers helping us to appraise the submissions in our journal continues to enlarge on a yearly basis. The number of readers accessing our data is huge. The citations of our articles continue to increase at a steady pace. The production values of our journal are excellent and our exacting standards of image reproduction are now being followed by other journals.

It goes without saying that the current stature of the journal is nothing but a reflection of the accomplishments of the previous editors. As I had averred at the time of taking over as the editor of this journal, my primary aim has been to maintain the momentum, keep up the good work and preserve the positive characters of the journal painstakingly etched by my predecessors. It has, indeed, been an exercise in continuity.4 Though sounding minimalist, on retrospectoscope, achievement of this aim has required great effort, which could not be done without the world-class editorial team that I was fortunate to build and lead. I am acutely aware that the outcomes have not always matched the quantum of our efforts. I take the sole responsibility for the limitations which have arisen or have persisted despite putting in my best for the journal during every day of the past seven odd years (including one year as editor-elect).

Having said that, we could also find some time and energy to make a few changes and innovations which, we hope, may be counted among worthwhile legacies for the journal for some time to come.

While we took the decision to make the editorial team less anonymous at the time I took over, recasting the Editorial Board to display the respective responsibilities of the individual members, a new cadre of editors, namely Image Editors, formally came to be recognized, certainly a rare event in the history of biomedical journals.

A team of specialised editors, named Language Editors, was conceptualised and created by my predecessor, Dr M Ramam. This was an innovation of necessity, given that IJDVL has been a favoured vehicle for non-English speaking authors, and the journal never have had the luxury of really efficient copy-editing services rendered by the publishers. Besides, readability has always been accorded a premium in this journal, even though, or perhaps, because of the fact that medical discourse is often dry and arcane.5 We renamed this group as Content Editors, recognizing that their job was not only to make articles more readable, but also to perform post-peer review editing of provisionally accepted manuscripts.

Thus, a multilayered editorial team, tasked with triage editing (Assistant Editors), conducting and moderating the peer review system (Section Editors), image editing (Image Editors) and post-peer review language and content editing (Content Editors) form the crux of the IJDVL Editorial Team. The editorial workflow, first enunciated by Dr Ramam in 2016 in an editorial,6 has been streamlined over the years. Notable changes were made during the changeover to a new online manuscript manager, EditorialAssist™, in 2020. We significantly customised the system as well as our processes over a period of time, taking advantage of a software where the editorial and production workflows were fully systematised and aligned together. We took our lessons from the repeated brainstorming sessions that we had in order to hasten our article processing, a perennial bugbear of this journal,7,8 and strived to develop a workflow that is as efficient as any. The current IJDVL review process and workflow have been depicted through figs. 1 and 2.

Figure 1:: The current IJDVL review process
Figure 2:: The current IJDVL editorial workflow. EIC: Editor-in-Chief; MS: Manuscript; AOP: Ahead of print;TOC: Table of contents; PDF: Portable document format.

We would not make any tall claim, however, regarding the necessity of speeding up our article processing time further, plagued by human factors all the time as it is. Furthermore, in the publication of a scientific journal, there is always this tension between the opposing demands of achieving speed in the article processing and the necessity of publishing data that is as valid and authentic as it can be. I would unabashedly admit that our editorial policy always veered towards the latter whenever we had to choose between one of the above. To us, the sanctity of our peer review process was inviolate.9 As we saw it, accuracy and integrity in the published work in a clinical journal like ours can be truly termed, without being hyperbolic at all, as a matter of life and death. Without it, unquestionably, a lot of people could be harmed. On all these occasions, our guiding light was a famous statement by Jerome P. Kassirer, a celebrated ex-editor of the New England Journal of Medicine: “Good editing and careful peer review do not guarantee that a journal’s content is accurate, reliable, and reproducible, but these practices do increase the likelihood of these attributes.”10

Closely related to this predilection was my explicit interest in evidence-based dermatology that led to the decisions of publishing only pre-registered interventional studies, meta-analyses and systematic reviews and creating a dedicated space for systematic reviews and meta-analyses. We also made the submission of CONSORT 2010 (for clinical trials) and PRISMA (for systematic reviews and meta-analyses) checklists and flowcharts mandatory.11 This may sound bureaucratic, but it goes a long way in transparent reporting. The principle is simple: “Place your bet and show us your hand”.12

On the opposite side of the spectrum, we introduced a slew of article categories, namely Pearls, Musings and Snippets which would attempt to stimulate a reading experience quite different from the dry, heavy-going and increasingly technical nature of medical science reporting. This was borne from our conviction that the discussion of clinical problems and even the exchange and transmission of complex scientific issues and innovations can be made easygoing and engaging. Likewise, in articles reporting original research, that is in the article categories of Original Articles, Brief Reports, Award Articles, Net Studies and Systematic Reviews and Meta-Analyses – sections particularly prone to having technical verbiage – we introduced Plain Language Summary that should be understood even by lay people. In the same vein, we introduced video documentation in IJDVL to showcase new therapeutic pearls. In another attempt to bring the journal down to earth from its vantage of ivory tower existence, we introduced a regular IJDVL session in every DERMACON (National Conference of IADVL), where the editors are open to praise and pillory by our readers, and are bound to answer every question, however uncomfortable those might be.

In IJDVL, we have always given prominence to letters, a very important segment of scientific communication. In keeping with that, we have increased the number of awards in the Letters category from three to five - one each for the best case letters, observation letters, therapy letters, study letters and net letters.

A noteworthy addition during this period was the Award Article – a category for original articles based on research for postgraduate dissertation. Cash awards, both for the postgraduate student and the research guide, were introduced and the awardees would be felicitated in the national conference of IADVL. This was done to promote qualitative improvement in curricular research with a hope that it would facilitate the research ecosystem of Indian clinical dermatology.13 Every year, we used to publish one or two Award Articles since its inception. Last year, there was none because of lack of submissions. We only hope that this unique endeavour does not die a premature death due to our faculty and students taking the easy way out and opting for publishing their research in questionable journals having a less exacting or, sometimes, a nonexistent peer review process. It is a matter of concern that such avenues of publication are not only thriving, but also multiplying steadily, including doppelgangers of our own IJDVL.14

We should also mention here that the 2019 Journal Citation Report saw IJDVL attain a historic Journal Impact Factor (JIF) level of 3.030. For four years (2017–20), IJDVL was the highest ranked scholarly journal published from India across all disciplines (all sciences including biomedical and health sciences, physical sciences and mathematics, technology and engineering, social sciences and the arts and humanities), as per the JIF. For the record, this was despite the remarkably JIF-unfriendly editorial decisions, manifested by IJDVL not getting submerged by the tide of Covid-heavy submissions during the pandemic and refusing to publish those without due diligence; denying to brand the journal as a vehicle of the so-called ‘skin of colour’ articles;15 or, by taking the plunge during the middle of a pandemic to change the publisher. Perhaps, most importantly, the Editorial Board never succumbed to the temptation of jettisoning the basic character of IJDVL as a core clinical journal on a global platform under the blinding, scrutinising glare of impact factors and did not relentlessly pursue the target of achieving ever higher JIFs only for the sake of it.16 This was entirely a possibility, however, and would have killed the soul of this journal.

Among the sundry limitations of the current team, the failure to properly utilise social media should be prominently listed. For this, the ambivalent editorial attitude toward social media and its role in biomedical publishing,17 as well as lack of resources, including the perennial financial penury of the journal, would have to blame. Though we introduced videos, more innovative and widespread use of multimedia is possible and necessary in biomedical journal publishing in the 21st century. Despite some attempts, we could not introduce the same. We did discontinue with the practice of seeking submissions for Case Reports, but that had less to do with any gambit for increasing the journal impact factor, and had more to do with our inability to editorially justify the distinction between case reports and letters. There was a remarkable lack of invited articles during this period, including symposium articles, as there was always a concern that the invited authors might find it too laborious to comply to our peer review process. Also, despite my numerous efforts, I failed to improve the financial situation of the journal.

Once again, I thank the numerous remarkable individuals who have collaborated with me in the editorial team during the past half a dozen years. I also thank our current publisher, Mr Pritesh Sheth in particular, for creating an enabling environment for our authors, reviewers and editors by customising the manuscript management system according to our demands at every step, big and small. I could not survive this tenure but for the immense help rendered by Tapas Kayal, our indefatigable Editorial Assistant, every single day.

The IJDVL editor has the onerous responsibility to manage the journal funds along with the sundry editorial responsibilities. At a time when the pharmaceutical industry has shown hardly any enthusiasm to support an editorial dispensation impervious to commercial interests, it has been a humongous job for Dr Rajeev Sharma, our long-serving (and, I may venture to add, long-suffering) Managing Editor, to secure advertisements and keep the journal running. It is to his eternal credit that the journal working funds have not dried up completely.

To go back to the quote by Dr Kassirer at the beginning of this Editorial, editing is a lonesome job. It tests the patience of even the best of the best. In this context, I am immensely grateful to members of my team and others (especially my family, Tapas and Pritesh, and not necessarily in that order), who had to bear the brunt of my impatience on numerous occasions. Along with many others, myself included, my family would perhaps be the most relieved to see my departure from this journal. They have waited long enough.

I welcome Prof Archana Singal, along with her team, in the hot seat. I wish her all success in this position, which is as demanding and as gratifying as any, from the core of my heart.


  1. . Publishing in the time of pandemic: Editorial policy of a dermatology journal during COVID–19. Indian J Dermatol Venereol Leprol. 2020;86:337-40.
    [CrossRef] [PubMed] [Google Scholar]
  2. . IJDVL 2020-21. Indian J Dermatol Venereol Leprol. 2021;87:751-2.
    [CrossRef] [PubMed] [Google Scholar]
  3. , . IJDVL: Journey of a journal. Indian J Dermatol Venereol Leprol. 2022;88:703-5.
    [CrossRef] [PubMed] [Google Scholar]
  4. . An exercise in continuity. Indian J Dermatol Venereol Leprol. 2017;83:153.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , . What the IJDVL expects from authors: Better writing. Indian J Dermatol Venereol Leprol. 2021;87:151-3.
    [CrossRef] [Google Scholar]
  6. . The manuscript review process: What do editors do? Indian J Dermatol Venereol Leprol. 2016;82:599-602.
    [CrossRef] [PubMed] [Google Scholar]
  7. . Article processing speed in the Indian Journal of Dermatology, Venereology and Leprology. Indian J Dermatol Venereol Leprol. 2020;86:471-4.
    [CrossRef] [PubMed] [Google Scholar]
  8. . Concluding remarks. Indian J Dermatol Venereol Leprol. 2017;83:1-3.
    [CrossRef] [PubMed] [Google Scholar]
  9. . The peer review process: Yesterday, today and tomorrow. Indian J Dermatol Venereol Leprol. 2019;85:239-45.
    [CrossRef] [PubMed] [Google Scholar]
  10. . Unanticipated Outcomes: A Medical Memoir In: Independent (Self-Published) (Kindle Edition). .
    [Google Scholar]
  11. , . Research waste is universal. Indian J Dermatol Venereol Leprol. 2022;88:447-9.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . Clinical trials submitted to the JID: Place your bet and show us your hand. J Invest Dermatol. 2015;135:325-7.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Encouraging curricular research: A new agenda for IJDVL. Indian J Dermatol Venereol Leprol. 2017;83:627-9.
    [CrossRef] [PubMed] [Google Scholar]
  14. . Predatory journals. Indian J Dermatol Venereol Leprol. 2020;86:109-14.
    [CrossRef] [PubMed] [Google Scholar]
  15. , . Skin of Colour: The IJDVL View. Indian J Dermatol Venereol Leprol. 2022;88:583-5.
    [CrossRef] [Google Scholar]
  16. . IJDVL and impact factor. Indian J Dermatol Venereol Leprol. 2018;84:525-7.
    [CrossRef] [PubMed] [Google Scholar]
  17. . Medical journalism and social media: A boon and a bane? Indian J Dermatol Venereol Leprol. 2018;84:647-51.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views

PDF downloads
View/Download PDF
Download Citations
Show Sections